
Lantern Pharma Investor Relations Material
Latest events

Q3 2024
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma is a clinical stage biotechnology company whose clinical programs target patients that have limited or poor options. Lantern's revolutionary AI platform, RADR®, uses leading edge machine learning techniques to help optimize drug development and clinical trial design, identify potential new indications for approved drugs, and improve the success of oncology clinical trials.
Key slides for Lantern Pharma Inc


Q2 2024
Lantern Pharma Inc


Q4 2023
Lantern Pharma Inc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
LTRN
Country
🇺🇸 United States